468 related articles for article (PubMed ID: 24991967)
21. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Tasneem U; Siddiqui MT; Faryal R; Shah AA
J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
[TBL] [Abstract][Full Text] [Related]
22. Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China.
Zeng ZR; Tian G; Ding YH; Yang K; Liu JB; Deng J
BMC Infect Dis; 2019 Nov; 19(1):939. PubMed ID: 31699043
[TBL] [Abstract][Full Text] [Related]
23. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.
Pu S; Niu S; Zhang C; Xu X; Qin M; Huang S; Zhang L
J Microbiol Immunol Infect; 2017 Feb; 50(1):97-103. PubMed ID: 25769664
[TBL] [Abstract][Full Text] [Related]
25. Fluconazole and echinocandin resistance of
Szekely J; Rakchang W; Rattanaphan P; Kositpantawong N
Epidemiol Infect; 2023 Aug; 151():e146. PubMed ID: 37622338
[TBL] [Abstract][Full Text] [Related]
26. Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medellín, Colombia 2010-2011.
Maldonado NA; Cano LE; De Bedout C; Arbeláez CA; Roncancio G; Tabares AM; Robledo CG; Robledo J;
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):280-6. PubMed ID: 24666706
[TBL] [Abstract][Full Text] [Related]
27. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.
Enwuru CA; Ogunledun A; Idika N; Enwuru NV; Ogbonna F; Aniedobe M; Adeiga A
Afr Health Sci; 2008 Sep; 8(3):142-8. PubMed ID: 19357740
[TBL] [Abstract][Full Text] [Related]
28. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
Aquino VR; Lunardi LW; Goldani LZ; Barth AL
Braz J Infect Dis; 2005 Oct; 9(5):411-8. PubMed ID: 16410893
[TBL] [Abstract][Full Text] [Related]
29. Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.
De Francesco MA; Piccinelli G; Gelmi M; Gargiulo F; Ravizzola G; Pinsi G; Peroni L; Bonfanti C; Caruso A
Mycopathologia; 2017 Oct; 182(9-10):897-905. PubMed ID: 28597394
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
32. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles.
Diba K; Makhdoomi K; Nasri E; Vaezi A; Javidnia J; Gharabagh DJ; Jazani NH; Reza Chavshin A; Badiee P; Badali H; Fakhim H
Microb Pathog; 2018 Dec; 125():240-245. PubMed ID: 30240817
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
34. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
35. Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
Lyon GM; Karatela S; Sunay S; Adiri Y;
J Clin Microbiol; 2010 Apr; 48(4):1270-5. PubMed ID: 20129963
[TBL] [Abstract][Full Text] [Related]
36. Species distribution and antifungal susceptibility profile of Candida isolates from blood and other normally sterile foci from pediatric ICU patients in Tehran, Iran.
Mirhendi H; Charsizadeh A; Eshaghi H; Nikmanesh B; Arendrup MC
Med Mycol; 2020 Feb; 58(2):201-206. PubMed ID: 31111910
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
38. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
Andes DR; Safdar N; Baddley JW; Alexander B; Brumble L; Freifeld A; Hadley S; Herwaldt L; Kauffman C; Lyon GM; Morrison V; Patterson T; Perl T; Walker R; Hess T; Chiller T; Pappas PG;
Transpl Infect Dis; 2016 Dec; 18(6):921-931. PubMed ID: 27643395
[TBL] [Abstract][Full Text] [Related]
39. Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry.
Neofytos D; Huprikar S; Reboli A; Schuster M; Azie N; Franks B; Horn D
Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):135-41. PubMed ID: 23907587
[TBL] [Abstract][Full Text] [Related]
40. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
